Insurer’s Actos Lawsuit Claims Drug Companies Failed to Warn of Bladder Cancer Risk, Bernstein Liebh

The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. New York, New York (PRWEB) June 15, 2014 An insurance company has filed an Actos lawsuit (http://www.theactoslawsuitcenter.com/) in the U.S. District Court, Western District of Louisiana, alleging that the manufacturers of the Type 2 diabetes medication failed to warn that long-term use of the drug could increase a patient’s risk of developing bladder cancer. The complaint, which was filed on June 11, 2014, seeks to recoup the cost of m
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations